Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
Cowen, Longwood add $735M to biopharma's pool of money
3 years ago
Startups
Radioantibody startup led by prostate cancer experts raises $90M
3 years ago
Morphic Therapeutic follows positive data readout for UC drug with $240M public offering
3 years ago
ARTHEx nabs Series B for clinical trial of ASO in myotonic dystrophy as Vertex’s deals heat up the space
3 years ago
Startups
Durham startup raises Series A to tackle undruggable proteins, including cancer baddie Myc, with generative AI
3 years ago
Startups
AI
Milestone Monday for Immatics’ Bristol Myers-allied cell therapy and 2seventy bio’s Novo-partnered hemophilia A work
3 years ago
Pharma
Cell/Gene Tx
'Undruggable is only at a given point in time': Prominent California scientists launch Initial Therapeutics with $75M
3 years ago
Startups
Acelyrin sets out for a 2021-sized IPO for California biotech’s PhIII drug
3 years ago
People
Startups
One SPAC inks biotech merger, while another linked to former Biden cancer moonshot leader will shut down
3 years ago
Deals
Foresight Diagnostics' approach for the earlier detection of cancer recurrence pulls in nearly $59M
3 years ago
Pattern Bioscience raises $28.7M Series C for faster, more efficient antibiotic resistance test
3 years ago
Diagnostics
‘Sleeping blockbuster’: MPM leads $53M Series E for Antiva as biotech seeks second go at tackling HPV
3 years ago
Exclusive: Therini raises $36M, will target fibrin protein for Alzheimer's and diabetic macular edema
3 years ago
Startups
Evommune raises $50M to fund clinical trials in skin diseases
3 years ago
Startups
With $270M, Beam spinoff Orbital Therapeutics builds RNA medicines as it hunts for partners, more delivery tech
3 years ago
Startups
Cell/Gene Tx
J&J's consumer health spinout Kenvue lines up a $3B+ IPO, biggest health offering since 2018
3 years ago
Pharma
Ideaya goes forward with $150M offering after touting PhII cancer data
3 years ago
R&D
Pfizer-backed Vedanta Biosciences lands $106M for PhIII in C. diff, PhII in IBD
3 years ago
Startups
PharmaEssentia secures $462M+ to further growth of Besremi and its pipeline
3 years ago
R&D
Chinese biotech startup adds $315M to the bank after bringing 5 Takeda drugs to its fold
3 years ago
China
Abdera raises $110M to push targeted radiotherapies where they haven’t gone before
3 years ago
Legend raises $200M from private investor after conference leaks PhIII Carvykti data
3 years ago
Cell/Gene Tx
Vaxcyte to raise $500M from stock offering for PhIII study of pneumococcal vaccine
3 years ago
Gilde Healthcare bags $657M to fuel 'holistic' search for affordable drugs, technologies
3 years ago
First page
Previous page
35
36
37
38
39
40
41
Next page
Last page